ROBERT W DUGGAN Insider Trading
Get free email notifications about insider trading for ROBERT W DUGGAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT W DUGGAN. ROBERT W DUGGAN is a Chairman and CEO in PHARMACYCLICS INC ($PCYC) and a 10% Owner in Achaogen Inc ($AKAO) and an Chief Executive Officer in Summit Therapeutics Inc. ($SMMT) and a 10% Owner in Pulse Biosciences, Inc. ($PLSE) and a Director in Pulse Biosciences, Inc. ($PLSE).
Companies in which ROBERT W DUGGAN is an Insider
Achaogen, Inc.
Trading Symbol: AKAOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT W DUGGAN: 10% Owner
Holdings: 6,561,423 shares
Current Value: $123,682,824
Latest Transaction: Mar 20 2019
$AKAO Market Capitalization: $541.33M
$AKAO Previous Close: $18.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PHARMACYCLICS INC
Trading Symbol: PCYCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT W DUGGAN: Chairman and CEO
Holdings: 0 shares
Latest Transaction: May 28 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Pulse Biosciences, Inc.
Trading Symbol: PLSEIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ROBERT W DUGGAN: Director, 10% Owner
Holdings: 11,659,781 shares
Current Value: $77,770,739
Latest Transaction: Dec 30 2020
$PLSE Market Capitalization: $95.47M
$PLSE Previous Close: $6.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Summit Therapeutics Inc.
Trading Symbol: SMMTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT W DUGGAN: Chief Executive Officer
Holdings: 67,662,454 shares
Latest Transaction: May 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ROBERT W DUGGAN
Sentiment: All, AKAO, PCYC, PLSE, SMMT
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2021 | SMMT | Summit Therapeutic ... | DUGGAN ROBERT W | Chief Executive Off ... | Buy | P | 5.24 | 11,365,921 | 59,557,426 | 67,662,454 | 56.3 M to 67.7 M (+20.19 %) |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | X | 7.01 | 8,214 | 57,580 | 0 | |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | X | 7.01 | 376,065 | 2,636,216 | 0 | |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Buy | X | 7.01 | 8,214 | 57,580 | 330,019 | 321.8 K to 330 K (+2.55 %) |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | X | 7.01 | 8,214 | 57,580 | 0 | |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Buy | X | 7.01 | 376,065 | 2,636,216 | 11,659,781 | 11.3 M to 11.7 M (+3.33 %) |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | X | 7.01 | 376,065 | 2,636,216 | 0 |